Literature DB >> 3986523

Antagonism of brain opioid peptide action reduces hibernation bout duration.

A L Beckman, C Llados-Eckman.   

Abstract

The effect of continuous intracerebroventricular (i.c.v.) administration of naloxone on the duration of individual bouts of hibernation was investigated in the golden-mantled ground squirrel (Citellus lateralis). Following entrance into hibernation, naloxone was continuously administered by an osmotic minipump at a rate of 1 microliter/h through a chronically implanted unilateral i.c.v. cannula guide. Naloxone (1, 5 and 7.5 micrograms/microliter) produced a dose-dependent reduction in hibernation bout duration ranging from 1 to 4 days (13.9-62.3% of expected bout duration). These data suggest that selected endogenous opioid system neurons may contribute to the CNS maintenance of the hibernating state and, consequently, to the overall conservation of energy in this species.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3986523     DOI: 10.1016/0006-8993(85)91030-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

1.  Identification of qRT-PCR reference genes for analysis of opioid gene expression in a hibernator.

Authors:  Jessica P Otis; Laynez W Ackermann; Gerene M Denning; Hannah V Carey
Journal:  J Comp Physiol B       Date:  2009-12-23       Impact factor: 2.200

2.  Gene expression in the brain across the hibernation cycle.

Authors:  B F O'Hara; F L Watson; H K Srere; H Kumar; S W Wiler; S K Welch; L Bitting; H C Heller; T S Kilduff
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

Review 3.  The neuroendocrine system in hibernating mammals: present knowledge and open questions.

Authors:  F Nürnberger
Journal:  Cell Tissue Res       Date:  1995-09       Impact factor: 5.249

Review 4.  Central nervous system regulation of mammalian hibernation: implications for metabolic suppression and ischemia tolerance.

Authors:  Kelly L Drew; C Loren Buck; Brian M Barnes; Sherri L Christian; Brian T Rasley; Michael B Harris
Journal:  J Neurochem       Date:  2007-06-06       Impact factor: 5.372

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.